SGM
RBOT

Seven Grand Managers’s Vicarious Surgical RBOT Stock Holding History

Seven Grand Managers’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,667
Closed -$295K – 47
2023
Q3 		$295K Buy
+16,667
New +$607K 0.4% 26

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Seven Grand Managers's RBOT Position: Q4 2023 in Review

Seven Grand Managers sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 16,667 shares — an estimated $295K sold.

Seven Grand Managers first reported a position in RBOT in Q3 2023 and held it in 1 quarter. The position peaked at $295K in Q3 2023. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

  • Seven Grand Managers reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
  • Seven Grand Managers sold 16,667 Vicarious Surgical shares in Q4 2023, an estimated $295K.
  • Seven Grand Managers first reported a position in Vicarious Surgical in Q3 2023 and held it in 1 quarter.
  • Seven Grand Managers's Vicarious Surgical position peaked at $295K in Q3 2023.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Seven Grand Managers's 13F filing for Q4 2023, filed 7 Feb 2024.